Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Leinco Technologies Inc Anti-Mouse NK1.1 (Natural Killer Cells, KR-P1C, NKR-P1B, Ly-55, CD161b, CD161c) In Vivo GOLD; Clone PK136; Isotype: Mouse IgG2a κ
SDP

Supplier:  Leinco Technologies Inc N1231.0 MG

Encompass_Preferred

Specificity: Clone PK136 recognizes mouse NK1.1. Antigen Distribution: NK-1.1 is encoded by the NKR-P1B/NKR-P1C gene and expressed on NK cells and NK-T cells in some mouse strains, including C57BL/6, FVB/N, and NZB, but not AKR, BALB/c, CBA/J, C3H, DBA/1, DBA/2, NOD, SJL, and 129. Background: Both the lysis of tumor cells In vitro and rejection of bone marrow allografts In vivo have been correlated with the expression of NK-1.1(NKR-P1C). NK-1.1 and DX5 are regularly used as mouse NK cell markers. Applications: (IP, WB, B) Proliferation of a subset of NK cells can be induced when combining plate-bound PK136 with low concentrations of IL-2. Leinco’s In vivo GOLDTM and In vivo PLATINUMTM functional antibodies are manufactured in an animal free facility using only In vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.

Catalog No. 50-190-6555


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.